BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yongping Zhou, Qian Wei, Junsheng Fan, Sijin Cheng, Wenzhou Ding, Zhiyuan Hua. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patientsClinica Chimica Acta 2018; 479: 181 doi: 10.1016/j.cca.2018.01.024
2
Carl J. DeSelm, Zachary E. Tano, Anna M. Varghese, Prasad S. Adusumilli. CAR T-cell therapy for pancreatic cancerJournal of Surgical Oncology 2017; 116(1): 63 doi: 10.1002/jso.24627
3
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial watch: Immunogenic cell death induction by anticancer chemotherapeuticsOncoImmunology 2017; 6(12): e1386829 doi: 10.1080/2162402X.2017.1386829
4
Andreas Henriksen, Anne Dyhl-Polk, Inna Chen, Dorte Nielsen. Checkpoint inhibitors in pancreatic cancerCancer Treatment Reviews 2019; 78: 17 doi: 10.1016/j.ctrv.2019.06.005
5
Chen Liu, He Cheng, Guopei Luo, Yu Lu, Kaizhou Jin, Meng Guo, Quanxing Ni, Xianjun Yu. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancerInternational Journal of Oncology 2017; 51(2): 686 doi: 10.3892/ijo.2017.4032